Clinical Trial Update: Minocycline in Patients With Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for minocycline in patients with Alzheimer's disease; results were posted in 2014 (2014-09-25).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• Minocycline (minocycline)

Snippet

Sponsor: Huntington Medical Research Institutes | Conditions: Mild Cognitive Impairment, Alzheimer's Disease | Phase 2 | Status: COMPLETED | Results posted: 2014-09-25